RESUMEN
Purpose: We sought to determine whether big data from social media might reveal seasonal trends of conjunctivitis, most forms of which are nonreportable. Methods: Social media posts (from Twitter, and from online forums and blogs) were classified by age and by conjunctivitis type (allergic or infectious) using Boolean and machine learning methods. Based on spline smoothing, we estimated the circular mean occurrence time (a measure of central tendency for occurrence) and the circular variance (a measure of uniformity of occurrence throughout the year, providing an index of seasonality). Clinical records from a large tertiary care provider were analyzed in a similar way for comparison. Results: Social media posts machine-coded as being related to infectious conjunctivitis showed similar times of occurrence and degree of seasonality to clinical infectious cases, and likewise for machine-coded allergic conjunctivitis posts compared to clinical allergic cases. Allergic conjunctivitis showed a distinctively different seasonal pattern than infectious conjunctivitis, with a mean occurrence time later in the spring. Infectious conjunctivitis for children showed markedly greater seasonality than for adults, though the occurrence times were similar; no such difference for allergic conjunctivitis was seen. Conclusions: Social media posts broadly track the seasonal occurrence of allergic and infectious conjunctivitis, and may be a useful supplement for epidemiologic monitoring.
Asunto(s)
Blogging , Conjuntivitis Alérgica/epidemiología , Registros Electrónicos de Salud , Estaciones del Año , Medios de Comunicación Sociales , Adolescente , Adulto , Distribución por Edad , Niño , Preescolar , Conjuntivitis Alérgica/clasificación , Conjuntivitis Bacteriana/epidemiología , Conjuntivitis Viral/epidemiología , Femenino , Humanos , Lactante , Recién Nacido , Internet , Masculino , Distribución por Sexo , Adulto JovenRESUMEN
Vernal keratoconjunctivitis is an ocular allergy that is common in the pediatric age group. It is often chronic, severe, and nonresponsive to the available treatment options. Management of these children is difficult and often a dilemma for the practitioner. There is a need to simplify and standardize its management. To achieve this goal, we require a grading system to judge the severity of inflammation and an algorithm to select the appropriate medications. This article provides a simple and practically useful grading system and a stepladder algorithm for systematic treatment of these patients. Use of appropriate treatment modalities can reduce treatment and disease-related complications.
Asunto(s)
Algoritmos , Conjuntivitis Alérgica/clasificación , Conjuntivitis Alérgica/tratamiento farmacológico , Índice de Severidad de la Enfermedad , Conjuntivitis Alérgica/diagnóstico , Ciclosporina/uso terapéutico , Combinación de Medicamentos , Humanos , Inmunosupresores/uso terapéutico , Soluciones Oftálmicas , Tacrolimus/uso terapéuticoRESUMEN
Allergic conjunctivitis (AC) is an inflammatory disease of the conjunctiva caused mainly by an IgE-mediated mechanism. It is the most common type of ocular allergy. Despite being the most benign form of conjunctivitis, AC has a considerable effect on patient quality of life, reduces work productivity, and increases health care costs. No consensus has been reached on its classification, diagnosis, or treatment. Consequently, the literature provides little information on its natural history, epidemiological data are scarce, and it is often difficult to ascertain its true morbidity. The main objective of the Consensus Document on Allergic Conjunctivitis (Documento dE Consenso sobre Conjuntivitis Alérgica [DECA]), which was drafted by an expert panel from the Spanish Society of Allergology and Spanish Society of Ophthalmology, was to reach agreement on basic criteria that could prove useful for both specialists and primary care physicians and facilitate the diagnosis, classification, and treatment of AC. This document is the first of its kind to describe and analyze aspects of AC that could make it possible to control symptoms.
Asunto(s)
Alergia e Inmunología/normas , Antialérgicos/uso terapéutico , Conjuntivitis Alérgica/terapia , Inmunoterapia/métodos , Antialérgicos/normas , Conjuntivitis Alérgica/clasificación , Conjuntivitis Alérgica/diagnóstico , Conjuntivitis Alérgica/inmunología , Consenso , Diagnóstico Diferencial , Humanos , Inmunoterapia/normas , Valor Predictivo de las Pruebas , Índice de Severidad de la Enfermedad , Resultado del TratamientoRESUMEN
Allergic conjunctivitis (AC) is an inflammatory disease of the conjunctiva caused mainly by an IgE-mediated mechanism. It is the most common type of ocular allergy. Despite being the most benign form of conjunctivitis, AC has a considerable effect on patient quality of life, reduces work productivity, and increases health care costs. No consensus has been reached on its classification, diagnosis, or treatment. Consequently, the literature provides little information on its natural history, epidemiological data are scarce, and it is often difficult to ascertain its true morbidity. The main objective of the Consensus Document on Allergic Conjunctivitis (Documento dE Consenso sobre Conjuntivitis Alérgica [DECA]), which was drafted by an expert panel from the Spanish Society of Allergology and Spanish Society of Ophthalmology, was to reach agreement on basic criteria that could prove useful for both specialists and primary care physicians and facilitate the diagnosis, classification, and treatment of AC. This document is the first of its kind to describe and analyze aspects of AC that could make it possible to control symptoms (AU)
La conjuntivitis alérgica (CA), es una enfermedad inflamatoria que se produce en la conjuntiva ocular mediada predominantemente, por un mecanismo IgE. En la alergia ocular, la CA se considera la entidad más frecuente y, a pesar de ser la forma más benigna, supone para los pacientes una importante afectación en su calidad de vida, una disminución de su productividad laboral y un elevado gasto sanitario. En la actualidad, no existen criterios consensuados acerca de su clasificación, diagnóstico y tratamiento de tal manera que por los trabajos publicados es difícil conocer su historia natural, existen escasos datos sobre su epidemiologia y, a veces es complejo identificar su morbilidad real. El objetivo principal del Documento de Consenso sobre Conjuntivitis Alérgica (DECA) realizado por un grupo de expertos de las Sociedades Españolas de Alergología y Oftalmología, ha sido establecer de forma consensuada unos criterios básicos que puedan ser útiles tanto para los especialistas, como para los médicos de atención primaria y que faciliten el diagnóstico, la clasificación y el tratamiento de los pacientes con CA. Por primera vez se describen y analizan distintos aspectos que pueden servir de herramientas para establecer el control de los síntomas de la CA (AU)
Asunto(s)
Humanos , Conjuntivitis Alérgica/diagnóstico , Hipersensibilidad Inmediata/complicaciones , Conjuntivitis Alérgica/tratamiento farmacológico , Oftalmopatías/inmunología , Conjuntivitis Alérgica/clasificación , Diagnóstico DiferencialRESUMEN
PURPOSE: To evaluate the efficacy of using topical cyclosporin A 0.05% (Restasis) for the treatment of paediatric allergic conjunctivitis. METHODS: This retrospective study included consecutive cases of paediatric allergic conjunctivitis treated with Restasis between 2010 and 2013. Subjects with follow-up time less than 3 months after using Restasis were excluded. Itch severity score, symptom score, and sign score were compared before (baseline) and 3 months after using Restasis. RESULTS: In 27 eyes of 14 patients (mean age 10.8 ± 3.2 years), 44.4% had allergic conjunctivitis, 33.3% had vernal keratoconjunctivitis, and 22.2% had atopic keratoconjunctivitis. The mean duration of ocular symptoms was 20.4 ± 13.2 months. 92.6% of subjects were using steroid eye drop before Restasis. After 3 months of topical Restasis, there were statistically significant reductions in the symptom, sign, and itch severity scores compared with baseline (all P ≤ 0.001) and 78.6% of subjects were able to be tapered off steroid eye drops. CONCLUSION: Topical Restasis was effective and safe in significantly reducing ocular itchiness, sign, and symptom scores at 3 months after use in paediatric allergic ocular conditions.
Asunto(s)
Conjuntivitis Alérgica/tratamiento farmacológico , Ciclosporina/administración & dosificación , Inmunosupresores/administración & dosificación , Soluciones Oftálmicas/administración & dosificación , Administración Tópica , Adolescente , Pueblo Asiatico , Niño , Conjuntivitis Alérgica/clasificación , Conjuntivitis Alérgica/patología , Femenino , Hong Kong , Humanos , Masculino , Estudios Retrospectivos , Resultado del TratamientoRESUMEN
BACKGROUND: The conjunctival provocation test (CPT) is a diagnostic procedure for the assessment of allergic diseases. Photographs are taken before and after provocation increasing the redness of the conjunctiva due to hyperemia. OBJECTIVE: We propose and evaluate an automatic image processing pipeline for objective and quantitative CPT. METHOD: After scale normalization based on intrinsic image features, the conjunctiva region of interest (ROI) is segmented combining thresholding, edge detection and Hough transform. Redness of the ROI is measured from 0 to 1 by the average pixel redness, which is defined by truncated projection in HSV space. In total, 92 images from an observational diagnostic study are processed for evaluation. The database contains images from two visits for assessment of the test-retest reliability (46 images per visit). RESULT: All images were successfully processed by the algorithm. The relative redness increment correlates between the two visits with Pearson's r = 0.672 (p <â .001). Linear correlation of the automatic measure is larger than the manual measure (r = 0.59). This indicates a higher reproducibility and stability of the automatic method. CONCLUSION: We presented a robust and effective way to objectify CPT. The algorithm operates on low resolution, is fast and requires no manual input. Quantitative CPT measures can now be established as surrogate endpoint in controlled clinical trials.
Asunto(s)
Conjuntivitis Alérgica/diagnóstico , Hiperemia/diagnóstico , Interpretación de Imagen Asistida por Computador , Pruebas Inmunológicas/métodos , Rinitis Alérgica Estacional/diagnóstico , Algoritmos , Conjuntivitis Alérgica/clasificación , Hiperemia/clasificación , Fotograbar , Rinitis Alérgica Estacional/clasificación , Programas InformáticosRESUMEN
Ocular allergy includes several clinically different conditions that can be considered as hypersensitivity disorders of the ocular surface. The classification of these conditions is complex, and their epidemiology has not been adequately studied because of the lack of unequivocal nomenclature. Ocular allergy symptoms are often, but not always, associated with other allergic manifestations, mostly rhinitis. However, specific ocular allergic diseases need to be recognized and managed by a team that includes both an ophthalmologist and an allergist. The diagnosis of ocular allergy is usually based on clinical history and signs and symptoms, with the support of in vivo and in vitro tests when the identification of the specific allergic sensitization is required for patient management. The aims of this Task Force Report are (i) to unify the nomenclature and classification of ocular allergy, by combining the ophthalmology and allergy Allergic Rhinitis and its Impact on Asthma criteria; (ii) to describe current methods of diagnosis; (iii) to summarize the therapeutic options for the management of ocular allergic inflammation.
Asunto(s)
Conjuntivitis Alérgica/diagnóstico , Conjuntivitis Alérgica/clasificación , Conjuntivitis Alérgica/terapia , HumanosRESUMEN
PURPOSE: To observe morphological changes in the meibomian glands of patients with contact lens-related allergic conjunctivitis (CLAC) and to assess the relations between the morphological changes and eyelid and tear film parameters. METHODS: We observed subjects in four groups: 64 eyes of 64 contact lens (CL) wearers with CLAC, 77 eyes of 77 CL wearers without CLAC, 55 eyes of 55 patients with perennial allergic conjunctivitis (perennial AC), and 47 eyes of 47 healthy volunteers. The following tests were performed: slit-lamp examination, measurement of tear film breakup time, grading of morphological changes in meibomian glands (meiboscore) as assessed by noncontact meibography, grading of meibomian gland distortion in meibography, tear production as assessed by Schirmer's I test, and grading of meibum expression. RESULTS: The mean score for meibomian gland distortion was significantly higher in the CL wearers with CLAC than in the CL wearers without CLAC (p < 0.0001); it was also significantly higher in the non-CL wearers with perennial AC than in the non-CL wearers without perennial AC (p < 0.0001). There was no significant difference between the mean scores for meibomian gland distortion of the non-CL wearers with perennial AC and the CL wearers with CLAC (p = 0.27). The score for meibomian gland distortion was significantly positively correlated with the meibum score in the CL wearers with CLAC and with the meiboscore in the CL wearers without CLAC. CONCLUSION: CLAC is associated with an increase in meibomian gland distortion. Allergic reaction, rather than CL wear, appears to be responsible for the increase in meibomian gland distortion in patients with CLAC.
Asunto(s)
Conjuntivitis Alérgica/etiología , Lentes de Contacto/efectos adversos , Enfermedades de los Párpados/etiología , Glándulas Tarsales/patología , Adulto , Conjuntivitis Alérgica/clasificación , Enfermedades de los Párpados/clasificación , Femenino , Humanos , Masculino , Lágrimas/fisiologíaRESUMEN
PURPOSE: To establish current definition, classification and staging, and to develop diagnosis and treatment recommendations for ocular allergy, by using Delphi approach. METHODS: Ten Latin American experts on ocular allergy participated in a 4-round Delphi panel approach. Four surveys were constructed and answered by panelists. A two-thirds majority was defined as consensus. Definition, classification, staging and diagnosis and treatment recommendations were the main outcomes. RESULTS: "Ocular allergy" was proposed as the general term to describe ocular allergic diseases. Consensus regarding classification was not reached. Signs and symptoms were considered extremely important for the diagnosis. It was consensus that a staging system should be proposed based on the disease severity. Environmental control, avoidance of allergens and the use of artificial tears were recommended as first line treatment. The secondary treatment should include topical anti-histamines, mast cell stabilizers and multi actions drugs. Topical non-steroidal anti-inflammatory and vasoconstrictors were not recommended. Topical corticosteroids were recommended as third line of treatment for the most severe keratoconjunctivitis. Consensus was not reached regarding the use of systemic corticosteroids or immunosuppressant. Surgical approach and unconventional treatments were not recommended as routine. CONCLUSION: The task of creating guidelines for ocular allergies showed to be very complex. Many controversial topics remain unsolved. A larger consensus including experts from different groups around the world may be needed to further improve the current recommendations for several aspects of ocular allergy.
OBJETIVO: Estabelecer a definição, classificação e estadiamento e desenvolver recomendações para o diagnóstico e tratamento da alergia ocular, usando o método Delphi de consenso. MÉTODOS: Dez especialistas em alergia ocular da América Latina participaram do painel. Quatro rodadas de questionários foram respondidas pelos painelistas. Consenso foi definido quando houve 2/3 ou mais de concordância. Os aspectos principais avaliados foram: definição, classificação, estadiamento e recomendações para diagnóstico e tratamento da alergia ocular. RESULTADOS: "Alergia Ocular" foi proposto como termo geral para descrever as doenças alérgicas oculares. Consenso sobre classificação não foi atingido. Sinais e sintomas foram considerados extremamente importantes para o diagnóstico. Consenso foi atingido sobre a necessidade de se estabelecer um sistema de estadiamento baseado na gravidade da doença. Controle ambiental e de exposição a alérgenos e o uso de lágrimas artificiais foram considerados tratamento de primeira linha e o uso tópico de anti-histamínicos, estabilizadores de membranas de mastócitos e drogas de ação múltipla, como tratamento de segunda linha. Anti-inflamatórios não hormonais tópicos e vasoconstrictores não foram recomendados. Corticosteroides tópicos foram estabelecidos como terceira linha de tratamento para casos graves de ceratoconjuntivite. Consenso não foi obtido em relação ao uso sistêmico de corticosteróides e imunossupressores. Abordagem cirúrgica e tratamentos não convencionais não foram recomendados de rotina. CONCLUSÃO: O desafio de criar recomendações para diversos aspectos da alergia ocular mostrou-se muito complexo, muitos deles permanencendo ainda controversos. Consensos mais amplos podem ser necessários para melhorar as recomendações atuais referentes a importantes aspectos da alergia ocular.
Asunto(s)
Humanos , Conjuntivitis Alérgica , Conjuntivitis Alérgica/clasificación , Conjuntivitis Alérgica/diagnóstico , Conjuntivitis Alérgica/terapia , Técnica Delphi , Diagnóstico Diferencial , América Latina , Índice de Severidad de la EnfermedadRESUMEN
PURPOSE: To establish current definition, classification and staging, and to develop diagnosis and treatment recommendations for ocular allergy, by using Delphi approach. METHODS: Ten Latin American experts on ocular allergy participated in a 4-round Delphi panel approach. Four surveys were constructed and answered by panelists. A two-thirds majority was defined as consensus. Definition, classification, staging and diagnosis and treatment recommendations were the main outcomes. RESULTS: "Ocular allergy" was proposed as the general term to describe ocular allergic diseases. Consensus regarding classification was not reached. Signs and symptoms were considered extremely important for the diagnosis. It was consensus that a staging system should be proposed based on the disease severity. Environmental control, avoidance of allergens and the use of artificial tears were recommended as first line treatment. The secondary treatment should include topical anti-histamines, mast cell stabilizers and multi actions drugs. Topical non-steroidal anti-inflammatory and vasoconstrictors were not recommended. Topical corticosteroids were recommended as third line of treatment for the most severe keratoconjunctivitis. Consensus was not reached regarding the use of systemic corticosteroids or immunosuppressant. Surgical approach and unconventional treatments were not recommended as routine. CONCLUSION: The task of creating guidelines for ocular allergies showed to be very complex. Many controversial topics remain unsolved. A larger consensus including experts from different groups around the world may be needed to further improve the current recommendations for several aspects of ocular allergy.
Asunto(s)
Conjuntivitis Alérgica , Conjuntivitis Alérgica/clasificación , Conjuntivitis Alérgica/diagnóstico , Conjuntivitis Alérgica/terapia , Técnica Delphi , Diagnóstico Diferencial , Humanos , América Latina , Índice de Severidad de la EnfermedadRESUMEN
Ocular allergy is an inflammatory response of the conjunctival mucosa that also affects the cornea and eyelids. Allergic conjunctivitis includes seasonal allergic conjunctivitis (SAC), perennial allergic conjunctivitis (PAC), vernal keratoconjunctivitis (VKC), atopic keratoconjunctivitis (AKC) and giant papillary conjunctivitis (GPC). In general, allergic conditions involve mast cell degranulation that leads to release of inflammatory mediators and activation of enzymatic cascades generating pro-inflammatory mediators. In chronic ocular inflammatory disorders associated with mast cell activation such as VKC and AKC constant inflammatory response is observed due to predominance of inflammatory mediators such as eosinophils and Th2-generated cytokines. Antihistamines, mast-cell stabilizers, nonsteroidal anti-inflammatory agents, corticosteroids and immunomodulatory agents are commonly indicated for the treatment of acute and chronic allergic conjunctivitis. In recent years newer drug molecules have been introduced in the treatment of allergic conjunctivitis. This article reviews recent patents and emerging therapeutics in the treatment of allergic conjunctivitis.
Asunto(s)
Conjuntivitis Alérgica/tratamiento farmacológico , Corticoesteroides/uso terapéutico , Antiinflamatorios no Esteroideos/uso terapéutico , Conjuntivitis Alérgica/clasificación , Antagonistas de los Receptores Histamínicos/uso terapéutico , Humanos , Factores Inmunológicos/uso terapéutico , Mastocitos/fisiología , Patentes como Asunto , Linfocitos T/fisiologíaRESUMEN
Neste artigo, os autores fazem uma revisão bibliográfica sobre a conjuntivite alérgica e seus subtipos, abordando suas manifestações clinicas, fisiopatologia, diagnóstico e manejo específicos.
Asunto(s)
Conjuntivitis Alérgica , Conjuntivitis Alérgica/clasificación , Conjuntivitis Alérgica/diagnóstico , Conjuntivitis Alérgica/fisiopatologíaRESUMEN
PURPOSE: To develop a standardized clinical grading system for the management of patients with vernal keratoconjunctivitis (VKC) and to identify the risk factors associated with a worsened outcome of the disease, including decrease of visual acuity and ocular complications development. DESIGN: Retrospective cohort study. PARTICIPANTS: A total of 207 consecutive patients with VKC, referred to our Cornea and External Diseases Center from 1997 to 2007, were included in the study. A total of 110 of those patients were included in the follow-up study (range 1-10 years). METHODS: Classification and regression tree (CART) analysis was performed to separate the patients into 5 subgroups by therapeutic approach. Regression tree and multivariate logistic regression analyses were performed during follow-up to identify predictors of worse visual outcome. MAIN OUTCOME MEASURES: Age, gender, duration and course of disease, signs, symptoms, overall symptoms score, history of atopy, markers of allergy, best-corrected visual acuity, and therapy were collected at baseline and during follow-up. The number of relapses and number of patients with decreased visual acuity were also evaluated in the follow-up. RESULTS: A decision tree for VKC treatment was developed by CART analysis, and a new clinical grading system was proposed accordingly. Sixteen patients were classified as grade 0 (absence of symptoms and no therapy); 59 patients were classified as grade 1 (presence of symptoms without photophobia, occasional use of anti-allergic eye drop); 74 patients were classified as grade 2 (presence of symptoms including photophobia, daily anti-allergic treatment); 22 patients with superficial punctuate keratopathy (SPK) were classified as grade 3 (daily anti-allergic treatment associated with occasional topical steroid); and 36 patients were classified as grade 4 (diffuse SPK or corneal ulcer; pulsed high-dose topical steroid). A higher number of relapses and a higher baseline grade of VKC were the main predictor factors for worse visual outcome. CONCLUSIONS: This grading system allows for identifying the more severe forms of VKC that are at higher risk of recurrences, corneal ulceration, and worse final visual outcome. FINANCIAL DISCLOSURE(S): The author(s) have no proprietary or commercial interest in any materials discussed in this article.
Asunto(s)
Antialérgicos/uso terapéutico , Conjuntivitis Alérgica/clasificación , Conjuntivitis Alérgica/tratamiento farmacológico , Glucocorticoides/uso terapéutico , Adolescente , Adulto , Niño , Preescolar , Conjuntivitis Alérgica/fisiopatología , Árboles de Decisión , Quimioterapia Combinada , Femenino , Estudios de Seguimiento , Humanos , Masculino , Análisis Multivariante , Recurrencia , Estudios Retrospectivos , Factores de Riesgo , Agudeza Visual/fisiologíaAsunto(s)
Conjuntivitis Alérgica/diagnóstico , Conjuntivitis Alérgica/terapia , Higiene/normas , Hipersensibilidad/terapia , Guías de Práctica Clínica como Asunto , Prevención Primaria/normas , Antialérgicos/uso terapéutico , Asma/complicaciones , Conjuntivitis Alérgica/clasificación , Conjuntivitis Alérgica/etiología , Dermatitis Atópica/complicaciones , Progresión de la Enfermedad , Humanos , Hipersensibilidad/complicaciones , Queratoconjuntivitis/diagnóstico , Queratoconjuntivitis/terapia , Enfermedades Profesionales/complicaciones , Soluciones Oftálmicas/uso terapéutico , Polonia , Sociedades Médicas/normasRESUMEN
BACKGROUND: The clinical features of allergic ocular diseases (AOD) are characterized by their wide variety. Clinical evaluation criteria are essential not only for objective assessment in clinical trials, but also for clinical studies on etiological aspects of AOD. However, there have been no internationally established criteria for clinical evaluation and classification of the severity of AOD. We established new criteria and applied them to many cases of AOD, and evaluated their usefulness for clinical purposes. We also studied whether each clinical entity of AOD [allergic conjunctivitis (AC), atopic keratoconjunctivitis (AKC), and vernal keratoconjunctivitis (VKC)] can be distinguished by these criteria. METHODS: A prospective study was carried out to assess the differential diagnosis of 1079 patients with AOD (439 male and 640 female patients). Differential diagnosis of AC, AKC or VKC was made. These diseases were diagnosed and classified based on local and systemic clinical findings. Ten objective ocular clinical findings of conjunctival, limbal and corneal lesions were graded on a 4-point scale, and the total score, with a highest value of 30, was used as the clinical score. RESULTS: Among a total of 1079 cases, seasonal allergic conjunctivitis (SAC), perennial allergic conjunctivitis (PAC), AKC and VKC accounted for 876 (81.2%), 115 (10.6%), 47 (4.4%) and 41 (3.8%) respectively. The mean age in each disease was 52.9, 56.1, 25.7 and 16.6 years respectively. Total clinical score in SAC, PAC, AKC and VKC was 1.54, 2.13, 3.72 and 12.68 respectively. Both mean age and total clinical score in all combinations of two diseases showed significantly different results. CONCLUSIONS: These results suggest that AOD can be classified by our new clinical grading system, and this system is sensitive enough for clinical evaluation of AOD. Re-evaluation of AOD is essential for constructing future strategies for the treatment of AOD, which are consists of various categories of ocular disorders.
Asunto(s)
Conjuntivitis Alérgica/diagnóstico , Conjuntivitis Alérgica/epidemiología , Adolescente , Adulto , Distribución por Edad , Conjuntivitis Alérgica/clasificación , Diagnóstico Diferencial , Femenino , Humanos , Masculino , Persona de Mediana Edad , Estudios ProspectivosAsunto(s)
Humanos , Niño , Enfermedades de los Anexos/clasificación , Orzuelo/terapia , Blefaritis/diagnóstico , Blefaritis/etiología , Conjuntivitis Alérgica/clasificación , Conjuntivitis Bacteriana , Conjuntivitis Viral/terapia , Signos y Síntomas/clasificación , Técnicas de Diagnóstico OftalmológicoRESUMEN
El ojo es uno de los órganos más sensibles y está permanentemente expuesto a diversos agentes ambientales. Dado que la conjuntiva es un tejido inmunológicamente activo, no es sorprendente que sea un sitio común de respuestas alérgicas. Las alergias oculares son un grupo de enfermedades que afectan la superficie conjuntival y están asociadas usualmente a reacciones de hipersensibilidad tipo 1. Pueden ser divididas en varias categorías: conjuntivitis alérgica estacional, conjuntivitis alérgica perenne, queratoconjuntivitis vernal y queratoconjuntivitis atópica.La inflamación de la superficie ocular produce prurito, lagrimeo, edema conjuntival y fotofobia. Como en otras enfermedades alérgicas, se puede desarrollar una condición crónica, acompañada de remodelación de los tejidos oculares. Las estrategias para el tratamiento de la alergia ocular han aumentado exponencialmente y los clínicos disponen de un inventario cada vez mayor de agentes dirigidos a la protección del ojo contra la inflamación. En este trabajo presentamos una revisión sobre las principales formas de alergia ocular, haciendo énfasis en el cuadro clínico, el diagnóstico y las nuevas opciones terapéuticas disponibles en la actualidad.
Asunto(s)
Conjuntivitis Alérgica/clasificación , Queratoconjuntivitis/clasificación , Rinitis Alérgica PerenneRESUMEN
PURPOSE OF REVIEW: Atopic keratoconjunctivitis (AKC), the most severe and chronic form of ocular surface allergy-related disorder, is the ocular surface complication that some atopic dermatitis patients can suffer. Its wide range of severity, from mild and occasional problems to persistent and intense inflammation, makes it difficult to appropriately select uniform patients for clinical studies. This article proposes a new classification system for AKC based on clinical severity. RECENT FINDINGS: Recent reports on AKC have contributed to a better understanding of the pathogenesis and clinical manifestations, and are offering new therapeutic candidates for AKC. No reports, however, have been found that address a classification of this disease. SUMMARY: A new definition and classification for AKC is presented by this review, based on clinical severity, grading the main symptoms and signs. It intends to serve as a first forum of discussion among clinicians and other scientists working in the field of ocular surface inflammation. The final intention is to have a common language helping develop efficient clinical trials leading to successful approval of new therapeutic compounds for this blinding ocular surface condition.
Asunto(s)
Conjuntivitis Alérgica/fisiopatología , Queratoconjuntivitis/fisiopatología , Conjuntivitis Alérgica/clasificación , Conjuntivitis Alérgica/inmunología , Humanos , Queratoconjuntivitis/clasificación , Queratoconjuntivitis/inmunologíaRESUMEN
Allergic conjunctivitis is a frequent disorder, benign in most cases and often associated with other manifestations of atopy such as rhinitis or asthma. This disorder is increasing steadily because of the influence of environmental factors such as pollution, smoking, etc. Allergic conjunctivitis can be broken down into five clinical forms: (1) seasonal and intra-annual conjunctivitis, (2) vernal keratoconjunctivitis, (3) atopic keratoconjunctivitis, (4) gigantopapillary conjunctivitis, and (5) contact allergies (palpebral conjunctival form). Analysis of the patterns and signs of the disorder as well as the circumstances surrounding its manifestation and an allergy workup generally facilitate eliminating the allergen responsible once it has been identified.
Asunto(s)
Conjuntivitis Alérgica/clasificación , Adulto , Alérgenos/efectos adversos , Asma/complicaciones , Asma/inmunología , Niño , Conjuntivitis Alérgica/complicaciones , Conjuntivitis Alérgica/inmunología , Conjuntivitis Alérgica/patología , Lentes de Contacto/efectos adversos , Dermatitis por Contacto/complicaciones , Dermatitis por Contacto/inmunología , Eccema/complicaciones , Eccema/inmunología , Enfermedades de los Párpados/complicaciones , Enfermedades de los Párpados/inmunología , Femenino , Humanos , Hipersensibilidad Inmediata/complicaciones , Hipersensibilidad Inmediata/inmunología , Masculino , Persona de Mediana Edad , Complicaciones Posoperatorias/inmunología , Rinitis Alérgica Perenne/complicaciones , Rinitis Alérgica Perenne/inmunología , Rinitis Alérgica Estacional/complicaciones , Rinitis Alérgica Estacional/inmunologíaRESUMEN
Allergic conjunctivitis is one of the most frequent reasons for a child's consultation with an ophthalmologist. Once the diagnosis of conjunctivitis is made and the clinical form is clearly established, the search for a cause is the most complicated step. Consultation with an allergist is necessary, in particular when questioning the patient points toward an allergic cause or brings up conditions suggestive of atopic disease. Ocular allergy can follow a type I hypersensitivity, i.e., mediated by IgE: most frequently this is acute and chronic allergic conjunctivitis. Demonstrating the allergen requires prick tests, which are easy to carry out and painless; their sensitivity is currently satisfactory. In vitro tests can complete the workup. In case of doubt on the allergen responsability for allergy, an allergenic provocation test can confirm or refute the allergen's involvement. Ocular allergy can also stem from a type IV mechanism, i.e., a cell-mediated mechanism such as in contact allergy involving different topical substances. In these cases, the clinical aspect and the patient's history may require consultation with a dermatologist-allergist for patch tests. To adapt practices when encountering conjunctivitis in a child, the ophthalmologist should be familiar with the allergens that may set off a conjunctivitis episode. Knowledge of the mechanisms at play also helps direct the examination toward allergy or another cause. In all these steps, collaboration between the ophthalmologist and the allergist is indispensable.